Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Therapeutic Advances in Urology
|
October 2, 2015
Cytoreductive nephrectomy and its role in the present-day period of targeted therapy
Stephen H Culp
Nature Clinical Practice. Urology
|
February 11, 2009
Should patients undergoing surgery for renal cell carcinoma have a lymph node dissection?
Stephen H Culp, Christopher G Wood
European Urology
|
December 3, 2013
Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study
Stephen H Culp, Paul F Schellhammer, Michael B Williams
Annals of Surgical Oncology
|
June 28, 2018
Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis
Matthew B Clements, Tracey L Krupski, Stephen H Culp
Urologic Oncology
|
April 9, 2014
Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era
Stephen H Culp, Jose A Karam, Christopher G Wood
Urologia Internationalis
|
August 8, 2020
Prostate Cancer Characteristics in the US Preventive Services Task Force Grade D Era: A Single-Center Study and Meta-Analysis
Matthew B Clements, Basil Abdalla, Stephen H Culp, et al.
The Journal of Urology
|
August 20, 2024
Impact of SPY Fluorescence Angiography on Incidence of Ureteroenteric Stricture After Urinary Diversion
Clinton Yeaman, Grace Ignozzi, Aisha Kazeem, et al.
Telemedicine Reports
|
August 15, 2024
Patient Satisfaction with a Novel Tele-Cystoscopy Model: Expanding Access to Bladder Cancer Surveillance for Rural Patients
Aisha O Kazeem, William Hasken, Terran Sims, et al.
BJU International
|
April 17, 2010
Identifying the risk of disease progression after surgery for localized renal cell carcinoma
E Jason Abel, Stephen H Culp, Matthew Meissner, et al.
European Urology
|
July 26, 2011
Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib
E Jason Abel, Stephen H Culp, Nizar M Tannir, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Therapeutic Advances in Urology
|
October 2, 2015
Cytoreductive nephrectomy and its role in the present-day period of targeted therapy
Stephen H Culp
Nature Clinical Practice. Urology
|
February 11, 2009
Should patients undergoing surgery for renal cell carcinoma have a lymph node dissection?
Stephen H Culp, Christopher G Wood
European Urology
|
December 3, 2013
Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study
Stephen H Culp, Paul F Schellhammer, Michael B Williams
Annals of Surgical Oncology
|
June 28, 2018
Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis
Matthew B Clements, Tracey L Krupski, Stephen H Culp
Urologic Oncology
|
April 9, 2014
Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era
Stephen H Culp, Jose A Karam, Christopher G Wood
Urologia Internationalis
|
August 8, 2020
Prostate Cancer Characteristics in the US Preventive Services Task Force Grade D Era: A Single-Center Study and Meta-Analysis
Matthew B Clements, Basil Abdalla, Stephen H Culp, et al.
The Journal of Urology
|
August 20, 2024
Impact of SPY Fluorescence Angiography on Incidence of Ureteroenteric Stricture After Urinary Diversion
Clinton Yeaman, Grace Ignozzi, Aisha Kazeem, et al.
Telemedicine Reports
|
August 15, 2024
Patient Satisfaction with a Novel Tele-Cystoscopy Model: Expanding Access to Bladder Cancer Surveillance for Rural Patients
Aisha O Kazeem, William Hasken, Terran Sims, et al.
BJU International
|
April 17, 2010
Identifying the risk of disease progression after surgery for localized renal cell carcinoma
E Jason Abel, Stephen H Culp, Matthew Meissner, et al.
European Urology
|
July 26, 2011
Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib
E Jason Abel, Stephen H Culp, Nizar M Tannir, et al.
Page
of 3